Fatty Liver in Hormone Receptor-Positive Breast Cancer and Its Impact on Patient's Survival

PURPOSE: Long-term estrogen inhibition may cause fatty liver disease (non-alcoholic fatty liver disease; NAFLD) among other adverse conditions such as osteoporosis, climacteric symptoms, thromboembolism, dyslipidemia, and metabolic syndrome. The prevalence of NAFLD among breast cancer patients range...

Descripción completa

Detalles Bibliográficos
Autores principales: Taroeno-Hariadi, Kartika Widayati, Putra, Yasjudan Rastrama, Choridah, Lina, Widodo, Irianiwati, Hardianti, Mardiah Suci, Aryandono, Teguh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561135/
https://www.ncbi.nlm.nih.gov/pubmed/34652078
http://dx.doi.org/10.4048/jbc.2021.24.e41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561135/
https://www.ncbi.nlm.nih.gov/pubmed/34652078
http://dx.doi.org/10.4048/jbc.2021.24.e41

Ejemplares similares